3D Systems Corporation
Non-GAAP Operating Income to Adjusted EBITDA Reconciliation
Three Months Ended March 31, 2022 and 2021
| Quarter Ended March 31, (1) | |||||||
| (in millions) | 2022 | 2021 | |||||
| Revenue | $ | 133.0 | $ | 146.1 | |||
| Non-GAAP Operating (loss) income | (3.9 | ) | 13.1 | ||||
| Depreciation | 5.8 | 6.7 | |||||
| Adjusted EBITDA | $ | 1.9 | $ | 19.8 | |||
| Adjusted EBITDA Margin | 1.4 | % | 13.6 | % | |||
(1)Amounts in table may not foot due to rounding
3D Systems Corporation
Reconciliation of Revenue Excluding Divestitures (Non-GAAP Measures) and Related Revenue Growth
Three Months Ended March 31, 2022 and 2021
(in Millions, unaudited)
|
Quarter Ended
March 31, 2022 |
Quarter Ended
March 31, 2021 | % Change | ||||||
| Revenue, as reported | ||||||||
| Healthcare | $ | 64.3 | $ | 72.5 | (11.3) % | |||
| Industrial | 68.7 | 73.6 | (6.7) % | |||||
| Total Revenue, as reported | $ | 133.0 | $ | 146.1 | (9.0) % | |||
| Revenue From Divestitures: | ||||||||
| Healthcare | $ | — | $ | 11.0 | ||||
| Industrial | — | 14.2 | ||||||
| Total Revenue | $ | — | $ | 25.2 | ||||
| Total Revenue (Excl. Divest.): | ||||||||
| Healthcare | $ | 64.3 | $ | 61.5 | 4.6 | % | ||
| Industrial | 68.7 | 59.4 | 15.7 | % | ||||
| Total Revenue (Excl. Divest.): | $ | 133.0 | $ | 120.9 | 10.0 | % | ||
